Click for best price
Antituberculosis Medicine Market Size, Share 2024
This report aims to provide a comprehensive presentation of the global market for Anti-tuberculosis Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-tuberculosis Medicine. This report contains market size and forecasts of Anti-tuberculosis Medicine in global, including the following market information:
Global Anti-tuberculosis Medicine Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Anti-tuberculosis Medicine Market Sales, 2019-2024, 2025-2030, (Kiliton)
Global top five Anti-tuberculosis Medicine companies in 2023 (%)
The global Anti-tuberculosis Medicine market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Isoniazid Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Anti-tuberculosis Medicine include Lupin, Macleods Pharmaceuticals, Otsuka Pharmaceutical, Johnson & Johnson, Pfizer, Novartis, Abbott, AstraZeneca and Bayer, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-tuberculosis Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-tuberculosis Medicine Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (Kiliton)
Global Anti-tuberculosis Medicine Market Segment Percentages, by Type, 2023 (%)
Isoniazid
Rifampin
Ethambutol
Pyrazinamide
Otherr
Global Anti-tuberculosis Medicine Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (Kiliton)
Global Anti-tuberculosis Medicine Market Segment Percentages, by Application, 2023 (%)
Hospitals and Clinics
Government Agencies
Non-Profit Organizations
Others
Global Anti-tuberculosis Medicine Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (Kiliton)
Global Anti-tuberculosis Medicine Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-tuberculosis Medicine revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Anti-tuberculosis Medicine revenues share in global market, 2023 (%)
Key companies Anti-tuberculosis Medicine sales in global market, 2019-2024 (Estimated), (Kiliton)
Key companies Anti-tuberculosis Medicine sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lupin
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer
Novartis
Abbott
AstraZeneca
Bayer
Eli Lilly
GlaxoSmithKline
Merck
Sanofi
Chongqing Huapont Pharm
Shuangding Pharm
Hongqi pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-tuberculosis Medicine, market overview.
Chapter 2: Global Anti-tuberculosis Medicine market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-tuberculosis Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-tuberculosis Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-tuberculosis Medicine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Anti-tuberculosis Medicine Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
116 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-tuberculosis Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-tuberculosis Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-tuberculosis Medicine Overall Market Size
2.1 Global Anti-tuberculosis Medicine Market Size: 2023 VS 2030
2.2 Global Anti-tuberculosis Medicine Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Anti-tuberculosis Medicine Sales: 2019-2030
3 Company Landscape
3.1 Top Anti-tuberculosis Medicine Players in Global Market
3.2 Top Global Anti-tuberculosis Medicine Companies Ranked by Revenue
3.3 Global Anti-tuberculosis Medicine Revenue by Companies
3.4 Global Anti-tuberculosis Medicine Sales by Companies
3.5 Global Anti-tuberculosis Medicine Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Anti-tuberculosis Medicine Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Anti-tuberculosis Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-tuberculosis Medicine Players in Global Market
3.8.1 List of Global Tier 1 Anti-tuberculosis Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-tuberculosis Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-tuberculosis Medicine Market Size Markets, 2023 & 2030
4.1.2 Isoniazid
4.1.3 Rifampin
4.1.4 Ethambutol
4.1.5 Pyrazinamide
4.1.6 Otherr
4.2 By Type - Global Anti-tuberculosis Medicine Revenue & Forecasts
4.2.1 By Type - Global Anti-tuberculosis Medicine Revenue, 2019-2024
4.2.2 By Type - Global Anti-tuberculosis Medicine Revenue, 2025-2030
4.2.3 By Type - Global Anti-tuberculosis Medicine Revenue Market Share, 2019-2030
4.3 By Type - Global Anti-tuberculosis Medicine Sales & Forecasts
4.3.1 By Type - Global Anti-tuberculosis Medicine Sales, 2019-2024
4.3.2 By Type - Global Anti-tuberculosis Medicine Sales, 2025-2030
4.3.3 By Type - Global Anti-tuberculosis Medicine Sales Market Share, 2019-2030
4.4 By Type - Global Anti-tuberculosis Medicine Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-tuberculosis Medicine Market Size, 2023 & 2030
5.1.2 Hospitals and Clinics
5.1.3 Government Agencies
5.1.4 Non-Profit Organizations
5.1.5 Others
5.2 By Application - Global Anti-tuberculosis Medicine Revenue & Forecasts
5.2.1 By Application - Global Anti-tuberculosis Medicine Revenue, 2019-2024
5.2.2 By Application - Global Anti-tuberculosis Medicine Revenue, 2025-2030
5.2.3 By Application - Global Anti-tuberculosis Medicine Revenue Market Share, 2019-2030
5.3 By Application - Global Anti-tuberculosis Medicine Sales & Forecasts
5.3.1 By Application - Global Anti-tuberculosis Medicine Sales, 2019-2024
5.3.2 By Application - Global Anti-tuberculosis Medicine Sales, 2025-2030
5.3.3 By Application - Global Anti-tuberculosis Medicine Sales Market Share, 2019-2030
5.4 By Application - Global Anti-tuberculosis Medicine Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Anti-tuberculosis Medicine Market Size, 2023 & 2030
6.2 By Region - Global Anti-tuberculosis Medicine Revenue & Forecasts
6.2.1 By Region - Global Anti-tuberculosis Medicine Revenue, 2019-2024
6.2.2 By Region - Global Anti-tuberculosis Medicine Revenue, 2025-2030
6.2.3 By Region - Global Anti-tuberculosis Medicine Revenue Market Share, 2019-2030
6.3 By Region - Global Anti-tuberculosis Medicine Sales & Forecasts
6.3.1 By Region - Global Anti-tuberculosis Medicine Sales, 2019-2024
6.3.2 By Region - Global Anti-tuberculosis Medicine Sales, 2025-2030
6.3.3 By Region - Global Anti-tuberculosis Medicine Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Anti-tuberculosis Medicine Revenue, 2019-2030
6.4.2 By Country - North America Anti-tuberculosis Medicine Sales, 2019-2030
6.4.3 US Anti-tuberculosis Medicine Market Size, 2019-2030
6.4.4 Canada Anti-tuberculosis Medicine Market Size, 2019-2030
6.4.5 Mexico Anti-tuberculosis Medicine Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Anti-tuberculosis Medicine Revenue, 2019-2030
6.5.2 By Country - Europe Anti-tuberculosis Medicine Sales, 2019-2030
6.5.3 Germany Anti-tuberculosis Medicine Market Size, 2019-2030
6.5.4 France Anti-tuberculosis Medicine Market Size, 2019-2030
6.5.5 U.K. Anti-tuberculosis Medicine Market Size, 2019-2030
6.5.6 Italy Anti-tuberculosis Medicine Market Size, 2019-2030
6.5.7 Russia Anti-tuberculosis Medicine Market Size, 2019-2030
6.5.8 Nordic Countries Anti-tuberculosis Medicine Market Size, 2019-2030
6.5.9 Benelux Anti-tuberculosis Medicine Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Anti-tuberculosis Medicine Revenue, 2019-2030
6.6.2 By Region - Asia Anti-tuberculosis Medicine Sales, 2019-2030
6.6.3 China Anti-tuberculosis Medicine Market Size, 2019-2030
6.6.4 Japan Anti-tuberculosis Medicine Market Size, 2019-2030
6.6.5 South Korea Anti-tuberculosis Medicine Market Size, 2019-2030
6.6.6 Southeast Asia Anti-tuberculosis Medicine Market Size, 2019-2030
6.6.7 India Anti-tuberculosis Medicine Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Anti-tuberculosis Medicine Revenue, 2019-2030
6.7.2 By Country - South America Anti-tuberculosis Medicine Sales, 2019-2030
6.7.3 Brazil Anti-tuberculosis Medicine Market Size, 2019-2030
6.7.4 Argentina Anti-tuberculosis Medicine Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-tuberculosis Medicine Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Anti-tuberculosis Medicine Sales, 2019-2030
6.8.3 Turkey Anti-tuberculosis Medicine Market Size, 2019-2030
6.8.4 Israel Anti-tuberculosis Medicine Market Size, 2019-2030
6.8.5 Saudi Arabia Anti-tuberculosis Medicine Market Size, 2019-2030
6.8.6 UAE Anti-tuberculosis Medicine Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Lupin
7.1.1 Lupin Company Summary
7.1.2 Lupin Business Overview
7.1.3 Lupin Anti-tuberculosis Medicine Major Product Offerings
7.1.4 Lupin Anti-tuberculosis Medicine Sales and Revenue in Global (2019-2024)
7.1.5 Lupin Key News & Latest Developments
7.2 Macleods Pharmaceuticals
7.2.1 Macleods Pharmaceuticals Company Summary
7.2.2 Macleods Pharmaceuticals Business Overview
7.2.3 Macleods Pharmaceuticals Anti-tuberculosis Medicine Major Product Offerings
7.2.4 Macleods Pharmaceuticals Anti-tuberculosis Medicine Sales and Revenue in Global (2019-2024)
7.2.5 Macleods Pharmaceuticals Key News & Latest Developments
7.3 Otsuka Pharmaceutical
7.3.1 Otsuka Pharmaceutical Company Summary
7.3.2 Otsuka Pharmaceutical Business Overview
7.3.3 Otsuka Pharmaceutical Anti-tuberculosis Medicine Major Product Offerings
7.3.4 Otsuka Pharmaceutical Anti-tuberculosis Medicine Sales and Revenue in Global (2019-2024)
7.3.5 Otsuka Pharmaceutical Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Anti-tuberculosis Medicine Major Product Offerings
7.4.4 Johnson & Johnson Anti-tuberculosis Medicine Sales and Revenue in Global (2019-2024)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Anti-tuberculosis Medicine Major Product Offerings
7.5.4 Pfizer Anti-tuberculosis Medicine Sales and Revenue in Global (2019-2024)
7.5.5 Pfizer Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Anti-tuberculosis Medicine Major Product Offerings
7.6.4 Novartis Anti-tuberculosis Medicine Sales and Revenue in Global (2019-2024)
7.6.5 Novartis Key News & Latest Developments
7.7 Abbott
7.7.1 Abbott Company Summary
7.7.2 Abbott Business Overview
7.7.3 Abbott Anti-tuberculosis Medicine Major Product Offerings
7.7.4 Abbott Anti-tuberculosis Medicine Sales and Revenue in Global (2019-2024)
7.7.5 Abbott Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Anti-tuberculosis Medicine Major Product Offerings
7.8.4 AstraZeneca Anti-tuberculosis Medicine Sales and Revenue in Global (2019-2024)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Bayer
7.9.1 Bayer Company Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Anti-tuberculosis Medicine Major Product Offerings
7.9.4 Bayer Anti-tuberculosis Medicine Sales and Revenue in Global (2019-2024)
7.9.5 Bayer Key News & Latest Developments
7.10 Eli Lilly
7.10.1 Eli Lilly Company Summary
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly Anti-tuberculosis Medicine Major Product Offerings
7.10.4 Eli Lilly Anti-tuberculosis Medicine Sales and Revenue in Global (2019-2024)
7.10.5 Eli Lilly Key News & Latest Developments
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Company Summary
7.11.2 GlaxoSmithKline Anti-tuberculosis Medicine Business Overview
7.11.3 GlaxoSmithKline Anti-tuberculosis Medicine Major Product Offerings
7.11.4 GlaxoSmithKline Anti-tuberculosis Medicine Sales and Revenue in Global (2019-2024)
7.11.5 GlaxoSmithKline Key News & Latest Developments
7.12 Merck
7.12.1 Merck Company Summary
7.12.2 Merck Anti-tuberculosis Medicine Business Overview
7.12.3 Merck Anti-tuberculosis Medicine Major Product Offerings
7.12.4 Merck Anti-tuberculosis Medicine Sales and Revenue in Global (2019-2024)
7.12.5 Merck Key News & Latest Developments
7.13 Sanofi
7.13.1 Sanofi Company Summary
7.13.2 Sanofi Anti-tuberculosis Medicine Business Overview
7.13.3 Sanofi Anti-tuberculosis Medicine Major Product Offerings
7.13.4 Sanofi Anti-tuberculosis Medicine Sales and Revenue in Global (2019-2024)
7.13.5 Sanofi Key News & Latest Developments
7.14 Chongqing Huapont Pharm
7.14.1 Chongqing Huapont Pharm Company Summary
7.14.2 Chongqing Huapont Pharm Business Overview
7.14.3 Chongqing Huapont Pharm Anti-tuberculosis Medicine Major Product Offerings
7.14.4 Chongqing Huapont Pharm Anti-tuberculosis Medicine Sales and Revenue in Global (2019-2024)
7.14.5 Chongqing Huapont Pharm Key News & Latest Developments
7.15 Shuangding Pharm
7.15.1 Shuangding Pharm Company Summary
7.15.2 Shuangding Pharm Business Overview
7.15.3 Shuangding Pharm Anti-tuberculosis Medicine Major Product Offerings
7.15.4 Shuangding Pharm Anti-tuberculosis Medicine Sales and Revenue in Global (2019-2024)
7.15.5 Shuangding Pharm Key News & Latest Developments
7.16 Hongqi pharmaceutical
7.16.1 Hongqi pharmaceutical Company Summary
7.16.2 Hongqi pharmaceutical Business Overview
7.16.3 Hongqi pharmaceutical Anti-tuberculosis Medicine Major Product Offerings
7.16.4 Hongqi pharmaceutical Anti-tuberculosis Medicine Sales and Revenue in Global (2019-2024)
7.16.5 Hongqi pharmaceutical Key News & Latest Developments
8 Global Anti-tuberculosis Medicine Production Capacity, Analysis
8.1 Global Anti-tuberculosis Medicine Production Capacity, 2019-2030
8.2 Anti-tuberculosis Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-tuberculosis Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-tuberculosis Medicine Supply Chain Analysis
10.1 Anti-tuberculosis Medicine Industry Value Chain
10.2 Anti-tuberculosis Medicine Upstream Market
10.3 Anti-tuberculosis Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-tuberculosis Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anti-tuberculosis Medicine in Global Market
Table 2. Top Anti-tuberculosis Medicine Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Anti-tuberculosis Medicine Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Anti-tuberculosis Medicine Revenue Share by Companies, 2019-2024
Table 5. Global Anti-tuberculosis Medicine Sales by Companies, (Kiliton), 2019-2024
Table 6. Global Anti-tuberculosis Medicine Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Anti-tuberculosis Medicine Price (2019-2024) & (US$/Ton)
Table 8. Global Manufacturers Anti-tuberculosis Medicine Product Type
Table 9. List of Global Tier 1 Anti-tuberculosis Medicine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-tuberculosis Medicine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Anti-tuberculosis Medicine Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Anti-tuberculosis Medicine Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Anti-tuberculosis Medicine Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Anti-tuberculosis Medicine Sales (Kiliton), 2019-2024
Table 15. By Type - Global Anti-tuberculosis Medicine Sales (Kiliton), 2025-2030
Table 16. By Application ? Global Anti-tuberculosis Medicine Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Anti-tuberculosis Medicine Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Anti-tuberculosis Medicine Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Anti-tuberculosis Medicine Sales (Kiliton), 2019-2024
Table 20. By Application - Global Anti-tuberculosis Medicine Sales (Kiliton), 2025-2030
Table 21. By Region ? Global Anti-tuberculosis Medicine Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Anti-tuberculosis Medicine Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Anti-tuberculosis Medicine Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Anti-tuberculosis Medicine Sales (Kiliton), 2019-2024
Table 25. By Region - Global Anti-tuberculosis Medicine Sales (Kiliton), 2025-2030
Table 26. By Country - North America Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Anti-tuberculosis Medicine Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Anti-tuberculosis Medicine Sales, (Kiliton), 2019-2024
Table 29. By Country - North America Anti-tuberculosis Medicine Sales, (Kiliton), 2025-2030
Table 30. By Country - Europe Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Anti-tuberculosis Medicine Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Anti-tuberculosis Medicine Sales, (Kiliton), 2019-2024
Table 33. By Country - Europe Anti-tuberculosis Medicine Sales, (Kiliton), 2025-2030
Table 34. By Region - Asia Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Anti-tuberculosis Medicine Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Anti-tuberculosis Medicine Sales, (Kiliton), 2019-2024
Table 37. By Region - Asia Anti-tuberculosis Medicine Sales, (Kiliton), 2025-2030
Table 38. By Country - South America Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Anti-tuberculosis Medicine Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Anti-tuberculosis Medicine Sales, (Kiliton), 2019-2024
Table 41. By Country - South America Anti-tuberculosis Medicine Sales, (Kiliton), 2025-2030
Table 42. By Country - Middle East & Africa Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Anti-tuberculosis Medicine Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Anti-tuberculosis Medicine Sales, (Kiliton), 2019-2024
Table 45. By Country - Middle East & Africa Anti-tuberculosis Medicine Sales, (Kiliton), 2025-2030
Table 46. Lupin Company Summary
Table 47. Lupin Anti-tuberculosis Medicine Product Offerings
Table 48. Lupin Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 49. Lupin Key News & Latest Developments
Table 50. Macleods Pharmaceuticals Company Summary
Table 51. Macleods Pharmaceuticals Anti-tuberculosis Medicine Product Offerings
Table 52. Macleods Pharmaceuticals Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 53. Macleods Pharmaceuticals Key News & Latest Developments
Table 54. Otsuka Pharmaceutical Company Summary
Table 55. Otsuka Pharmaceutical Anti-tuberculosis Medicine Product Offerings
Table 56. Otsuka Pharmaceutical Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 57. Otsuka Pharmaceutical Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Anti-tuberculosis Medicine Product Offerings
Table 60. Johnson & Johnson Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Anti-tuberculosis Medicine Product Offerings
Table 64. Pfizer Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 65. Pfizer Key News & Latest Developments
Table 66. Novartis Company Summary
Table 67. Novartis Anti-tuberculosis Medicine Product Offerings
Table 68. Novartis Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 69. Novartis Key News & Latest Developments
Table 70. Abbott Company Summary
Table 71. Abbott Anti-tuberculosis Medicine Product Offerings
Table 72. Abbott Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 73. Abbott Key News & Latest Developments
Table 74. AstraZeneca Company Summary
Table 75. AstraZeneca Anti-tuberculosis Medicine Product Offerings
Table 76. AstraZeneca Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 77. AstraZeneca Key News & Latest Developments
Table 78. Bayer Company Summary
Table 79. Bayer Anti-tuberculosis Medicine Product Offerings
Table 80. Bayer Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 81. Bayer Key News & Latest Developments
Table 82. Eli Lilly Company Summary
Table 83. Eli Lilly Anti-tuberculosis Medicine Product Offerings
Table 84. Eli Lilly Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 85. Eli Lilly Key News & Latest Developments
Table 86. GlaxoSmithKline Company Summary
Table 87. GlaxoSmithKline Anti-tuberculosis Medicine Product Offerings
Table 88. GlaxoSmithKline Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 89. GlaxoSmithKline Key News & Latest Developments
Table 90. Merck Company Summary
Table 91. Merck Anti-tuberculosis Medicine Product Offerings
Table 92. Merck Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 93. Merck Key News & Latest Developments
Table 94. Sanofi Company Summary
Table 95. Sanofi Anti-tuberculosis Medicine Product Offerings
Table 96. Sanofi Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 97. Sanofi Key News & Latest Developments
Table 98. Chongqing Huapont Pharm Company Summary
Table 99. Chongqing Huapont Pharm Anti-tuberculosis Medicine Product Offerings
Table 100. Chongqing Huapont Pharm Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 101. Chongqing Huapont Pharm Key News & Latest Developments
Table 102. Shuangding Pharm Company Summary
Table 103. Shuangding Pharm Anti-tuberculosis Medicine Product Offerings
Table 104. Shuangding Pharm Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 105. Shuangding Pharm Key News & Latest Developments
Table 106. Hongqi pharmaceutical Company Summary
Table 107. Hongqi pharmaceutical Anti-tuberculosis Medicine Product Offerings
Table 108. Hongqi pharmaceutical Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 109. Hongqi pharmaceutical Key News & Latest Developments
Table 110. Anti-tuberculosis Medicine Production Capacity (Kiliton) of Key Manufacturers in Global Market, 2021-2024 (Kiliton)
Table 111. Global Anti-tuberculosis Medicine Capacity Market Share of Key Manufacturers, 2021-2024
Table 112. Global Anti-tuberculosis Medicine Production by Region, 2019-2024 (Kiliton)
Table 113. Global Anti-tuberculosis Medicine Production by Region, 2025-2030 (Kiliton)
Table 114. Anti-tuberculosis Medicine Market Opportunities & Trends in Global Market
Table 115. Anti-tuberculosis Medicine Market Drivers in Global Market
Table 116. Anti-tuberculosis Medicine Market Restraints in Global Market
Table 117. Anti-tuberculosis Medicine Raw Materials
Table 118. Anti-tuberculosis Medicine Raw Materials Suppliers in Global Market
Table 119. Typical Anti-tuberculosis Medicine Downstream
Table 120. Anti-tuberculosis Medicine Downstream Clients in Global Market
Table 121. Anti-tuberculosis Medicine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-tuberculosis Medicine Segment by Type in 2023
Figure 2. Anti-tuberculosis Medicine Segment by Application in 2023
Figure 3. Global Anti-tuberculosis Medicine Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Anti-tuberculosis Medicine Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Anti-tuberculosis Medicine Revenue, 2019-2030 (US$, Mn)
Figure 7. Anti-tuberculosis Medicine Sales in Global Market: 2019-2030 (Kiliton)
Figure 8. The Top 3 and 5 Players Market Share by Anti-tuberculosis Medicine Revenue in 2023
Figure 9. By Type - Global Anti-tuberculosis Medicine Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Anti-tuberculosis Medicine Revenue Market Share, 2019-2030
Figure 11. By Type - Global Anti-tuberculosis Medicine Sales Market Share, 2019-2030
Figure 12. By Type - Global Anti-tuberculosis Medicine Price (US$/Ton), 2019-2030
Figure 13. By Application - Global Anti-tuberculosis Medicine Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Anti-tuberculosis Medicine Revenue Market Share, 2019-2030
Figure 15. By Application - Global Anti-tuberculosis Medicine Sales Market Share, 2019-2030
Figure 16. By Application - Global Anti-tuberculosis Medicine Price (US$/Ton), 2019-2030
Figure 17. By Region - Global Anti-tuberculosis Medicine Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Anti-tuberculosis Medicine Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Anti-tuberculosis Medicine Revenue Market Share, 2019-2030
Figure 20. By Region - Global Anti-tuberculosis Medicine Sales Market Share, 2019-2030
Figure 21. By Country - North America Anti-tuberculosis Medicine Revenue Market Share, 2019-2030
Figure 22. By Country - North America Anti-tuberculosis Medicine Sales Market Share, 2019-2030
Figure 23. US Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Anti-tuberculosis Medicine Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Anti-tuberculosis Medicine Sales Market Share, 2019-2030
Figure 28. Germany Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 29. France Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Anti-tuberculosis Medicine Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Anti-tuberculosis Medicine Sales Market Share, 2019-2030
Figure 37. China Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 41. India Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Anti-tuberculosis Medicine Revenue Market Share, 2019-2030
Figure 43. By Country - South America Anti-tuberculosis Medicine Sales Market Share, 2019-2030
Figure 44. Brazil Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Anti-tuberculosis Medicine Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Anti-tuberculosis Medicine Sales Market Share, 2019-2030
Figure 48. Turkey Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Anti-tuberculosis Medicine Revenue, (US$, Mn), 2019-2030
Figure 52. Global Anti-tuberculosis Medicine Production Capacity (Kiliton), 2019-2030
Figure 53. The Percentage of Production Anti-tuberculosis Medicine by Region, 2023 VS 2030
Figure 54. Anti-tuberculosis Medicine Industry Value Chain
Figure 55. Marketing Channels
